Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-002918
Filing Date
2017-01-09
Accepted
2017-01-09 16:06:05
Documents
1
Period of Report
2017-01-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3922
  Complete submission text file 0001209191-17-002918.txt   5408
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address
Stevens David R (Reporting) CIK: 0001292382 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35182 | Film No.: 17517556

Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Issuer) CIK: 0001411906 (see all company filings)

EIN.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations